MDN1 and cancer: While the precise role of midasin in cancer has yet to be determined, the robust increase in protein expression observed in the mammospheres, the expression of midasin in ductal carcinoma tissue samples, along with its involvement in RFS, supports its involvement in both endocrine sensitive and endocrine resistant breast cancer.